Centiva Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Centiva Capital’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,500	Closed	-$339K	–	982
2019 Q3	$339K	Buy	+3,500	New	+$350K	0.02%	414

Centiva Capital's ONCE Position: Q4 2019 in Review

Centiva Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 3,500 shares — an estimated $339K sold.

Centiva Capital first reported a position in ONCE in Q3 2019 and held it in 1 quarter. The position peaked at $339K in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Centiva Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Centiva Capital sold 3,500 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $339K.
Centiva Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
Centiva Capital's Spark Therapeutics, Inc. Common Stock position peaked at $339K in Q3 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Centiva Capital's 13F filing for Q4 2019, filed 14 Feb 2020.